De partm ents of B io med ica l Sciences and C linica l Medi cin e, Uni ve rsity of Ta mpere, Ta mpere, and Dcpa rtm cnt of De rm ato logy, U nive rsity of T ur ku, T urku , Finland We studi ed w hether Langerh ans cell (LC)-and T-l ymph ocy te fun ctions of atopi c derm atitis (AD) patients are impaired . O ur stud y g roups co nsisted of 6 patients with AD w ith previous disse minated herpes simplex virus infection (AD + HSV), 8 pati ents with o rdinary AD, and 5 health y subj ects. Suction blisters w ere performed on abdominal skin and LC isolated on th e basis of th eir attachm ent to IgG-coated erythrocy te monolayers. Anti gen-presenting fun ctio n of purified LC was studied by m eas uring th e proliferati on of HSV -stimul ated T cell s. Langerhans cells were also used to stimul ate T cells in autol ogo us mi xed cell reaction (AM C R). In addition, the production o f epidermal cell thymocy te-activating factor (ET AF) by crude epidermal cell s was m easured . cytes elabo rate biologicall y ac tive substances such as epiderm al th ymocy te-acti va ting fac to r (ET AF) [5] .
D efective cell-m edi ated immunity and o verpro ducti on of IgE are well-kno wn immun o logic abno rm alities in ato pic derm atitis (AD) [1] . Impaired defense mechanisms render these patien ts susceptibl e to severe cuta neous bacteri al, viral, and fun ga l infecti ons. The underl yin g cellul ar mechanisms in AD are at present fa r fro m clea r. T he m ain interest has been foc used on abno rm al ly mphocyte fun cti o n, whereasthe role o f other immun ologica ll y active cells like epidermal Langerhans cells (LC) has no t been cla rified. Langerhans cells are a subgroup of dendritic cells [2] and fo rm a part of skin-associated lympho id tiss ue [3] . T hey present antigens fo r T lymphocytes [4] and alo ng w ith keratin oManuscript rece ived August 19, 1986 ; acce pted fo r publi ca tion Dece mber 23, 1986 .
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Abbreviat ions: AD: ato pi c derm atitis AD + H SV: ato pic der mat itis w ith cutaneous herpes simplex virus in fec tio n AM CR : auto logous mi xed cel l reaction E IA : enzy me immunoassay ET AF: epiderm al cell thymocy te-acti va tin g fac to r IL-1: interl cukin 1 IL-2: interlcukin 2 LC: Langerhans cell (s) PM A: 4,B-phorbol 12-m yristate 13-ace tate SI: stimul ati on in dex SRBC: sheep red blood cells T he HSV-induced T-cell proliferation in AD + HSV and AD patients was co mparable w ith th at of controls. T he AMC R responses o f patients w ith AD + HSV and AD were clea rl y diminished w hen co mpared w ith health y controls. Pati ents with AD also produ ced significantl y less ET AF than controls. Our res ults sugges t th at HSV anti gen-presentin g fun ction of LC from patients with AD + HSV seems to be intact. D efective AMC R may refl ect an abno rmality in autoreg ul ation and generation of effector cells and this togeth er w ith decreased ET AF produ ction m ay have pathogenetic significance in AD. ] In vest D ermato ! 89: 15-1 8, 1987 cytes elabo rate biologicall y ac tive substances such as epiderm al th ymocy te-acti va ting fac to r (ET AF) [5] .
We studied w hether LC-fun cti on and T-cell fun cti o n are impaired in o rdinary pati ents w ith AD and those w ith previo us disseminated cutaneous herpes simplex vi rus infecti on (AD + H SV).
Langerhans cells were used as accesso ry cells in H SV -induced proli fe rati on of T -l ymphocytes and as stimulators in auto logous mi xed cell reacti on (AM C R) . In addition, the ability of epiderm al cells to produce ET AF was co mpared in pati ent and healthy contro l groups.
MATERIALS AND M ETHO D S
Patients and Healthy Controls O ur stud y po pulatiOli consisted of 5 hea lth y subjects, 8 o rdin ary pati ents with AD , and 6 ato pic pati ents w ith a histo ry o f cutaneous herpes virus infecti o ns (T able I) . Within the las t yea r, 5 of the pati ents had had at least 1 dissemin ated H SV -1 infecti on and 1 patient had suffered fro m H SV-l ence phalitis and several local cutaneous herpes infectio ns. Disseminated cutaneous infecti ons and enceph alitis had been verified by isolati on and typing and trea ted w ith acyclovir. A t the tim e of th e stud y none of the patients had acti ve her pes in fection .
Enrichment of Epidermal LC T he purificatio n procedu re of LC has been previo usly described in detail [6] . In brief, epide rmal sheets w ere trea ted with 0.25% tr ypsin (G IBCO Ltd. , Paisley, Scotl and) fo r 30 min at 37°C and then with 0.01 % DN ase I (Sig ma C hemical Co., St. Lo uis, Missouri) fo r 5 min at roo m te mperature. T he sheets w ere pipetted vigorously and the cell suspension filtered th ro ug h a n ylon mesh . The LC were isolated in tissue culture dishes by attaching them to sheep red blood cell (S RBC) m onola ye rs coated with anti-SRB C IgG (Ca ppel Labo rato ries Autologous Mixed Cell Reaction Cultures In th ese cultures . T ly mph ocy tes we re stimul ated w ith auto logous purifi ed LC. In preliminary ex pe rim ents it w as fo und th at o ptimum stimula to r to res po nder cell rati o w as 1: 1 and o ptimum culture tim e 7 da ys fo r bo th hea lth y contro ls and atopi c pati ents. Subsequentl y, 25,10 3 T cell s we re cultured in the presence o f 25·1U 3 LC in V-bo tto m ed mi cro p lates fo r 7 da ys . In so m e ex perim ents exogeno us inte rl eukin I (I L-l , fin al conce ntrati o n 10 units/ ml , Ge nzy m e Co rp ., N o rwa lk , Connecti cut), in te rlcukin 2 (IL-2, fin al conce ntrati o n Other Meth ods T o tal IgE va lues we re measured w ith a comm ercial nI ST kit (Pharm ac ia, Uppsa la, Sweden). Th e H SV-l antibo dies w ere m eas ured w ith an enzy m e immun o assay (E IA) as described pre vi o usly \9\ . Th e HSV is o lates we re ty ped usin g a co mmercial immun o Au o rescence kit (Sy va Co., Palo Alto , C alifo rni a).
RE SULTS T -Cell Proliferative Responses and Ser u m Antibodies to
HSV-l Ce ll-m edi ated imm unit y to H SV-l w as assessed in vitro by m easurin g the pro life rati o n of T lymph ocytes stimulated w ith a comm ercial anti gen preparati o n . Accessory cell s we re essenti al fo r T-cell b las t transfo rmati o n, and here we supplem ented th e cu ltures w ith 5% purified LC. T able II illus trates the res uits o f cell culture ex perim ents and serum antibo dy determin ati o ns in individu al cases . Three subj ects (numbers 5, 6, and 12) we re se ro ncga tivc to HSV-l and th cy also showed no res po nse to th c antigen prcparation in the b last transfo rm Jtio n tcst (stimulatio n in dices lcss than 3.0 we re considc rcd negativc) . Two subjccts (3 and 4) had cvidcntl y had prim ary infccti o n, and th cir in vitro rcs po nscs to HSV-l wc re relativcl y low. All seropositivc subjccts wc rc also positi vc in th e blast transform atio n test, but thcrc was no co rrelati o n bctwccn antibody levcls and m ag nitudc of Iy mph ocy tc rcs po nsivencss. Sin cc o nl y 2 subjccts w ith pos iti vc H SV-[gG antibo di cs wc rc includcd in o ur hea lth y co nt ro l g ro up, the rcs ults o n HSV-l-indu ced prolifc rati o n ca nnot be statistica ll y anaIyzcd among diffcrcn t s tudy g roups. However, it seems that scro pos iti ve atop ic patients w ith or w itho ut prcvi o us disse min ated HSV-l in fect ion rcs pond w ell to herpcs antigc ns in vitro.
H crpcs Si mplex Virus (H S V)-I-Indu ccd Pro li feratio n ofT Ly mph ocytcs, Scrum Antibod ics to HSV-I , Au to logous Mi xcd Ccll n.cac tions (AMR C) , and Gcneratio n o f Epidcrm al T hy m ocyte-A ctivatin g Facto r (ETA F) in Paticnts With Atopi c Dcrm atiti s and H ca lthy Contro ls

Autologous Mixed Cell Reaction and ET AF in Patient and
Control Groups Langerh ans cclls, du e to th eir DR antigcn , are ablc to stimul ate auto logo us T ly mph ocy tes to pro li fcratc. Th is reactio n was signifi ca ntl y impaircd (p < 0.0 1, M ann-Whitncy U tes t) in AD + H SV and AD g ro ups as co mparcd wit h thc contro ls (2.7 ± 0.7 , 2.5 ± 0.5, and 9.7 ± 1.9, m ca n stimulatio n indcx (S I) ± SE M , res pcctivel y). T hc AM C R was ncga ti vc (S I < 3.0) in 3/6 AD + H SV paticnts and 5/8 AD pati cnts but pos iti vc in all hca lth y subj ccts (Table II) . Dcfi cicnt AM C R did no t sec m to correlate w ith the severity of AD (Tables I, II ) .
Wc also meas urcd ET AF ac ti vity in cru de epidc rmal cell culturcs (Ta bl e II). Thc mean ± SE M va lucs in unitsl ml wc rc l 6. 7 ± 2.5, 8.0 ± 1. 1, and 6.0 ± 1.5 in healthy contro l, AD , and AD + HSV g ro ups, res pectivel y. Both AD and AD + HSV gro ups diffcred sig nifi cantly from th c contro ls (p < 0.0 1, Mann-Whitn cy U test). The ETAF va lues did no t co rrclatc with AM C n. o r activ ity o f AD . Intcrcstingly, o ur pa ti cnt w ith cnccphalitis had th e lowest ETAF and AM C R va lucs in spitc of good antibody levels and proliferativc responsive ncss to HSV-l.
[n AM C R, T cells bo th produ cc and res po nd to IL-2 110]. [nterl eukin 1 in turn promotes th c synthcsis of [L-2. We next studied w hethe r suppl ementatio n o f AM C R cultures w ith cxogeno us I L-\ , I L-2, o r both rcstorcs dcfi cicnt proli fcration. With 3 ato pic pati ents thc m ca n AM C n. rcs po nscs we rc 2.6 (c ulturcs not suppl em entcd w ith interlcukins), 3 .4 (in the prescncc o f exogcno us IL-\ ), 5.5 (in thc presencc of IL-2), and 8. 1 (cu lture sup plcm cnted w ith bo th IL-l and IL-2). In terleuk in 1 and IL-2 toge th c r thu s ca used the most distin ct cnhan ccmcnt of dcprcssed AM C n. .
D [SCUSS IO N
H cre we prcscnt ev idcnce th at the in vitro T-I y mphocytc respo nsivcncss o f H SV -l -scropositivc atopics to herpcs anti gcns is intact. H owcver, co mparcd w ith thc hca lthy con tro l g ro up , patic nts w ith AD havc dcfects in ET AF productio n and A M CR .
Ccll-m cd iatcd immunity to H SV was m easurcd by T -Iy mphocy tc pro li fc ratio n . In this systc m wc used cpidcrm al LC as antigcn-prcscnti ng ccll s. Wc and othc rs have prcvio usl y rcportcd that w ith scvera l antigcns LC are m o re cffccti vc acccsso ry cc ll s than arc m o nocytcs [11] [12] [13] . All seropositi vc subj ccts, w hether hca lth y o r atop ic, rcs po nded by bl as t transformation to H SV. H owcver, th cre sec m cd to bc no co rrelatio n b etvvcc n se rum antibody levels to H S V and m agnitud c of ly m phocyte rcs pon sc. We havc prcvi o usly obta in cd simil ar rcsults w ith mumps v irus 11 4] , and a rc inclin ed to beli cve th at thcsc findin gs illustrate a re al situ ati o n and arc no t du e to tcchni cal erro rs o r variability.
It is gc nerall y believed that ccll-mediated immunity is im pa ired in paticnts with AD and in crcascd susccptibility of these pa ti cnts to di sseminatcd cu taneous vira l infecti o ns is o nc m ani festation of defectivc immunity [1] . In vitro studies o n cc ll-m cd iatcd immunit y in paticnts w ith AD have g ivc n contradictory res ul ts. In m an y reports, anti gen-in d uced o r mitogcn-indu ccd T-ly mph ocy te pro li fe ratio n has been no rm al, w he reas othe r in vcs ti g ato rs have obtaincd diminishcd rcsponses, espcciall y in scvere forms of AD li S]. It seem s plausible that whcn lymphocytes arc activatcd with stro ng anti geni c o r mitogeni c stimulants, subtle changes in their res po nsivc ness ca nnot be dctcctcd . We believe that the AMC R used in the present stud y is sui table for detectin g even sli g ht de fects in cellular intera cti o ns.
In AM C R T lymp hocy tes are activated by their ow n DRpositi ve cells. Dendriti c cell s have been fou nd to be th e m os t potent autologous activa tors [1 6]. Autol ogous mi xed cell reaction has bee n observed to be impa ired in auto immun e, immun op roIifera tive, and atopic diseases [1 0, [17] [18] [19] . We are no t awa re of ea rli er reports in w hi ch strongly DR-positive LC we re used as stimulato r cell s in AM C R in atopic o r other diseases . In an y case, o ur res ults resemble th ose o btain ed by o th ers with no n-T cell s as auto logo us stimul ato rs [1 7 -19] . In o ur hands, defec ti ve A M C R co ul d be resto red by exogeno us IL-1 and IL-2 . Impaired AM C R ma y thus reflect diminished produ ctio n o r res po nse of both inte rleu kin s. Accord ing to newer conce pts, AM C R represents an immune circui t th at lea ds to the activation of helpe r, cyto tox ic, and sup presso r T lymph ocy tes 120]. Defective AM C R m ay be lin ked w ith dimini shed suppresso r and cytoto xic cell fun ction s o bserved earlier in AD [21] [22] [23] [24] . T lymp hocy tes reg ul ate IgE synth es is, and ove rprod uction o f IgE in atopic diseases is believed to be due, at least in part, to deficient suppresso r T-cell acti vity [25] . Further m o re, it has been specul ated w hether defec tive cytotoxic T-cell fun cti o n acco unts fo r the increased susceptibility of patients with AD to v ira l in fect io ns 1 2 1 I· It has recen tl y been ve rifi ed that both LC and keratin ocy tes p ro du ce ETAF [5] . E piderm al cell thym ocy te-activa tin g facto r is indi stin g ui shable from m o nocyte-derived IL-1 and has a multipli cit y of bio logic activities. It contributes to T-cell activa ti o n , possesses chem o tacti c activity for leukocy tes , medi ates fever, indu ces acu te-ph ase pro teins in the li ve r, an d stimulates fibrob las t prolifera ti o n 15]. M onocyte produ cti o n o f IL-1 has been o bserved to be d iminished in patients with AD [26] , but as far as wc know the im pa ired ca pacity of th eir epidermal cells to generate ETAF has no t bee n described ea rli er.
So m e of o ur patients had had num ero us loca l H SV infecti o n episodes in ad dition to o ne or two dissemin ated o nes in spite of the fac t that they developed secmin gly good hum o ral and cellm ed iated res po nses to this agen t. H erpes infectio ns tend to rec ur even in hea lth y individu als, but the infecti o n susceptibility of patients w ith AD is clea rl y grea ter. Th e diminished capacity of these patients to prod uce biologica ll y ac ti ve m edi ato rs such as ET A F, and th eir defective autoregu lation and ge neratio n of effector cell s m ay contribute to impaired defe nse.
